UNICA IRIS Institutional Research Information System

PISTIS, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 178.797
NA - Nord America 5.885
AS - Asia 966
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 6
OC - Oceania 3
Totale 185.677
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 177.253
US - Stati Uniti d'America 5.857
CN - Cina 705
UA - Ucraina 547
SE - Svezia 440
DE - Germania 158
GB - Regno Unito 156
SG - Singapore 153
FI - Finlandia 134
FR - Francia 55
VN - Vietnam 46
CA - Canada 25
KR - Corea 22
BE - Belgio 13
IN - India 12
EU - Europa 9
NL - Olanda 9
CZ - Repubblica Ceca 8
HK - Hong Kong 8
BR - Brasile 7
TR - Turchia 7
RU - Federazione Russa 6
IE - Irlanda 5
IR - Iran 5
AT - Austria 4
CR - Costa Rica 3
EG - Egitto 3
JP - Giappone 3
AR - Argentina 2
AU - Australia 2
ES - Italia 2
IL - Israele 2
RS - Serbia 2
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
ID - Indonesia 1
IQ - Iraq 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
Totale 185.677
Salva come PNG Salva come JPEG
Città #
Cagliari 176.878
Fairfield 915
Woodbridge 641
Chandler 435
Houston 411
Ashburn 396
Ann Arbor 383
Nyköping 339
Wilmington 337
Seattle 332
Cambridge 301
Jacksonville 267
Dearborn 192
Boardman 136
Shanghai 121
Nanjing 104
Beijing 93
New York 86
Boston 82
Singapore 67
Helsinki 60
San Diego 52
Dong Ket 46
Nanchang 38
Guangzhou 35
Milan 33
Hebei 32
Redwood City 29
Shenyang 29
London 24
Mountain View 24
Los Angeles 23
Jiaxing 22
Rome 22
Seoul 20
Hefei 19
Norwalk 18
Tianjin 18
Jinan 17
Toronto 17
Brussels 13
Kunming 13
Verona 13
Auburn Hills 12
Orange 12
San Mateo 12
Sèlegas 12
Augusta 11
Changsha 10
Taizhou 10
Washington 10
Zhengzhou 10
Leawood 9
Ningbo 9
Sassari 9
Wuhan 9
Hong Kong 8
Monmouth Junction 8
Phoenix 8
Quartu Sant'elena 8
Brno 7
Frankfurt am Main 6
Kilburn 6
Atlanta 5
Borås 5
Chicago 5
Dublin 5
Iglesias 5
Kocaeli 5
Pune 5
Shenzhen 5
Tappahannock 5
Torino 5
Villacidro 5
Araraquara 4
Falls Church 4
Fremont 4
Hounslow 4
Mondolfo 4
Shaoxing 4
Amsterdam 3
Ardabil 3
Brampton 3
Cairo 3
Chiswick 3
Detroit 3
Jinhua 3
Livorno 3
Marcon 3
Montague 3
New Bedfont 3
Parma 3
Pisa 3
Prescot 3
Saint Paul 3
San Francisco 3
San José 3
Vienna 3
Weng 3
Ancona 2
Totale 183.457
Salva come PNG Salva come JPEG
Nome #
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain 37.472
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 4.285
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 3.854
Maternal immune activation disrupts dopamine system in the offspring 3.758
Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis 3.152
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.142
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.101
null 2.940
Physiological role of peroxisome proliferator-activated receptors type alpha on dopamine systems 2.871
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling 2.673
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.582
Endocannabinoid signaling in motivation, reward, and addiction: influences on mesocorticolimbic dopamine function 2.500
null 2.498
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.410
null 2.394
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.296
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas 2.262
Effects of maternal immune activation on dopamine activity in male and female offspring 2.215
PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors 2.181
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats 2.166
PPAR-alpha: a new target for the treatment of nocturnal frontal lobe epilepsy 2.158
Inhibitory inputs from rostromedial tegmental nucleus regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse 2.118
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.029
Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: Involvement of the endocannabinoid system 2.029
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives 2.000
Trattamenti farmacologici per la dipendenza da nicotina 1.869
Dynamic interactions between drugs of abuse and the endocannabinoid system: molecular mechanisms and functional outcome 1.850
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 1.815
The role of nuclear hormone receptors in cannabinoid function 1.786
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 1.736
Pharmacological treatments for nicotine dependence 1.730
Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-α nuclear receptors 1.708
Opposite responses to aversive stimuli in lateral habenula neurons 1.704
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2 1.684
Neurobiologia della dipendenza da nicotina 1.656
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. 1.630
Characterization of wild-type (R100R) and mutated (Q100Q) GABA(A) alpha(6) subunit in Sardinian alcohol non-preferring rats (sNP) 1.621
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.620
Cannabinoid withdrawal: where does the hypodopaminergic state come from? 1.602
Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases 1.588
Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice 1.524
Neurobiology of nicotine addiction 1.521
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding 1.502
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.471
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings 1.453
Preclinical studies of cannabis addiction − relationships between the endocannabinoid and dopamine systems 1.450
Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features and emerging specificities of the two major endocannabinoids 1.418
ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL 1.416
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex 1.353
The endocannabinoid system and nondrug rewarding behaviours 1.337
Inhibition of anandamide hydrolysis differentially modulates cocaine-induced effects on rat mesolimbic system 1.306
Inhibition of anandamide hydrolysis antagonizes nicotine effects on neurons in the nucleus accumbens shell in the rat 1.276
Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus 1.265
Peroxisome proliferator activated receptors type alpha modulate nicotine effects in the rat ventral tegmental area 1.251
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.209
Environmental Tobacco Smoke During the Early Postnatal Period of Mice Interferes With Brain 18 F-FDG Uptake From Infancy to Early Adulthood – A Longitudinal Study 1.193
Neurobiological mechanisms of cannabinoid addiction 1.114
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons 1.102
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation 1.037
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1-and non-CB1-mediated actions 1.002
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: Evidence for GABAB receptor-mediated effects 977
Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo 964
Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons 960
Endocannabinoids and the processing of value-related signals 932
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 917
Involvement of the endogenus cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: Electrophysiological evidence in vivo 903
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors 892
null 850
null 841
null 800
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 763
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 759
null 747
Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction 688
Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology 675
Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors 668
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal 649
Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate 646
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 640
From surface to nuclear receptors: the endocannabinoid family extends its assets 636
Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate (GHB) receptor in the rat brain 614
Endocannabinoid signalling in midbrain dopamine neurons: more than physiology? 604
Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system 583
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation 579
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance 566
The R100Q mutation of the GABA(A) alpha(6) receptor subunit may contribute to voluntary aversion to ethanol in the sNP rat line 548
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 532
Braking Dopamine Systems: A New GABA Master Structure for Mesolimbic and Nigrostriatal Functions 532
Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study 510
Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition 490
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders 469
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. 439
Dietary Phospholipid-Bound Conjugated Linoleic Acid and Docosahexaenoic Acid Incorporation Into Fetal Liver and Brain Modulates Fatty Acid and N-Acylethanolamine Profiles 436
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy 432
Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity 417
Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study 371
General anaesthetic action at transmitter-gated inhibitory amino acid receptors 339
The GABAA receptor: an important locus for intravenous anaesthetic action 338
The selective interaction of neurosteroids with the GABAA receptor. 333
The 5-HT3B subunit is a major determinant of serotonin-receptor function 331
Totale 178.255
Salva come PNG Salva come JPEG
Categoria #
all - tutte 220.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 220.404
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202029.041 0 822 217 453 11.499 8.474 4.196 873 562 589 577 779
2020/202141.818 1.144 1.558 1.599 12.763 8.894 4.482 3.079 2.280 1.003 1.933 2.021 1.062
2021/202211.101 1.050 879 586 682 1.013 908 564 469 602 1.328 1.738 1.282
2022/202314.067 990 1.397 1.327 1.089 1.323 1.647 733 1.299 1.120 1.051 1.430 661
2023/202449.892 661 572 541 856 1.483 2.459 2.645 1.114 938 903 1.646 36.074
2024/20254.369 3.853 516 0 0 0 0 0 0 0 0 0 0
Totale 186.029